NW-8-124

N/A

Report date: 2025/04/02 11:26:23
NME

Base Information

Drug NameNW-8-124
Drug Alias NameNW-8-124NW-8124
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of Actionp53-binding protein Mdm-2 degraders
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Lupeng Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Lupeng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A